Vaxfab Enterprises Q4 FY26: Profit YoY -47%, Revenue ₹45.99cr

Overview: what changed in Vaxfab Enterprises’ latest quarter

Vaxfab Enterprises Ltd reported a sharp year-on-year decline in profit for the March 2026 quarter (Q4 FY26), based on the data points provided in the source. The company’s net profit for Q4 FY26 is stated at ₹2.14 crore, down -47.03% compared with the same period last year. At the same time, the same dataset says the company delivered a 166.05% quarter-on-quarter jump in net profit versus the previous three months. Revenue for the quarter is cited at ₹45.99 crore as on March 2026 (Q4 FY26). These figures matter because they point to a quarter where profitability trends look mixed depending on whether the comparison is year-on-year or sequential.

The source also provides multiple quarterly tables that do not fully align on sales and profit for the March 2026 quarter. Instead of smoothing those differences, the key is to read each table as presented and focus on the direction across operating profit, other income, and profit after tax where available. Investors typically track whether improvements are coming from core operations or from volatile non-operating items. That distinction becomes important in Vaxfab’s numbers due to the swings shown in “Other Income” across quarters.

Key Q4 FY26 snapshot from the provided data

For Q4 FY26 (March 2026 quarter), the source states revenue of ₹45.99 crore and net profit of ₹2.14 crore. It also flags that the net profit fell -47.03% year-on-year for the quarter. Sequentially, it states a 166.05% jump in net profit versus the prior quarter.

Alongside those headline figures, the source lists share price data points. One line says Vaxfab Enterprises’ share price stood at ₹64.95 at the close of the market. Another line in the dataset presents an answer stating the current share price is ₹60.75. Since both values appear in the provided text, they are best treated as separate snapshots from different screens or timestamps rather than a single definitive closing price.

Quarterly operating trend: sales and profit lines across FY25-FY26

The quarterly profit and loss table (figures in ₹ crore) lists the following operating sequence through December 2025: sales of ₹50.92 crore in March 2025, a dip to ₹14.57 crore in June 2025, a rise to ₹55.04 crore in September 2025, and ₹15.66 crore in December 2025. Total income follows a similar pattern, while expenses remain close to or above income in the weaker quarters. Operating profit compresses meaningfully over the period, moving from ₹6.37 crore (Dec 2024) and ₹4.24 crore (Mar 2025) down to ₹0.70 crore (Sep 2025) and ₹0.32 crore (Dec 2025).

The same table shows operating profit margin falling from 13.92% (Dec 2024) to 8.33% (Mar 2025), 7.28% (Jun 2025), and 1.27% (Sep 2025), before ticking to 2.04% (Dec 2025). That margin path suggests pressure on core profitability during the year, even before considering the effects of other income. The table also shows negative values for “Other Income” in multiple quarters, which further complicates the bridge from operating profit to net profit.

Other income and non-operating volatility in the quarter tables

A separate “Quarterly Result” table (all figures in ₹ crore) presents “Other Income” values that swing sharply: -0.63 crore (Jun 2025), -3.42 crore (Sep 2025), 0 (Dec 2025), and 9.53 crore (Mar 2026). In that table, despite an operating loss of -2.55 crore for March 2026, profit before tax is shown at ₹6.97 crore, supported by the large other income line. Tax is listed at ₹3.96 crore, leading to profit after tax of ₹3.02 crore for Mar 2026 in that table.

The presence of two sets of quarterly numbers increases the need to separate operating performance from non-operating gains or losses. When other income is negative, it can reduce profits even if operating profit is positive. And when other income spikes, profits can rise even with weak operating results. The tables provided in the source show both scenarios across adjacent quarters.

Table: quarterly results as provided (₹ crore)

The following table reproduces the “Quarterly Result” dataset from the source (all figures in ₹ crore, EPS in ₹).

Full-year figures and longer-term revenue reference points

For the full year FY2026–2027, the source states revenue reached ₹136.75 crore and profit was ₹-4.63 crore. That implies a loss for the full year on the figures provided, even though some quarters show positive profit after tax in the quarterly tables.

The dataset also states: “At the end of the last reported fiscal year, Vaxfab Enterprises (VAXF) recorded total revenue of 1,312.63 million INR.” Normalised into ₹ crore, that equals ₹131.26 crore. Since the exact fiscal year label is not clearly attached to that line in the provided text, it serves as an additional historical revenue reference rather than a directly comparable FY26 or FY27 number.

EPS and profitability indicators mentioned in the source

The source lists “Quarterly Earnings Growth YOY: -47.03” in the context of the profit decline. It also mentions “Vaxfab Enterprises EPS (TTM) -5.51.” In the quarterly profit and loss table, EPS values shown include 0.76 (Dec 2024), 0.48 (Mar 2025), -0.27 (Sep 2025), and -0.39 (Dec 2025), with blank entries for some quarters.

Separately, one line states: “Aktualnie wykazana marża zysku brutto spółki Vaxfab Enterprises (VAXF) wynosi -17,03%,” indicating a gross profit margin of -17.03% as presented in the dataset. The mix of negative margin and shifting EPS values matches the broader theme of uneven profitability.

Market view: share price snapshots provided

Two share price points appear in the provided text. One states the share price at market close was ₹64.95. Another states the current share price is ₹60.75. Without a timestamp and with both values present, readers should treat them as separate snapshots rather than a single verified closing price for the same session.

For investors following quarterly earnings, price reaction typically depends on whether the profit improvement is driven by operating strength or by other income, and whether full-year profitability is stabilising. The data here shows that those drivers can differ sharply quarter to quarter.

What investors may track next based on the numbers shown

Based on the tables provided, operating profit and operating margins weakened through much of FY25 into late 2025, with margins dropping to low single digits in some quarters. The “Other Income” line shows large swings, including negative figures in multiple quarters and a high positive value in March 2026 in one table. This combination can make net profit volatile even when revenue moves sharply between quarters.

Going forward, the most useful checks from the same set of metrics would be whether sales stabilise, whether operating profit turns consistently positive, and whether other income normalises. For readers looking at the FY2026–2027 full-year loss figure (₹-4.63 crore), the key accounting bridge is whether recurring operating performance can offset any non-operating fluctuations.

Conclusion

Vaxfab Enterprises’ Q4 FY26 profit trend is mixed in the provided dataset: a -47.03% year-on-year fall to ₹2.14 crore is reported alongside a 166.05% quarter-on-quarter increase. Revenue for Q4 FY26 is cited at ₹45.99 crore, while a separate quarterly table lists March 2026 net sales at ₹8.83 crore and profit after tax at ₹3.02 crore, highlighting inconsistencies across the supplied tables. The company’s FY2026–2027 revenue is stated at ₹136.75 crore with a full-year loss of ₹-4.63 crore. Investors will likely focus on how much of profitability is coming from operating profit versus swings in other income as new quarterly updates arrive.